Formulation of microencapsulated rutin and evaluation of bioactivity and stability upon in vitro digestive and dialysis conditions
Copyright © 2020 Elsevier B.V. All rights reserved..
Rutin, a flavanol, has been demonstrating excellent antioxidant, anti-inflammatory, anti-diabetic, and anti-carcinogenic properties. However, bioavailability is low due to low stability, solubility, digestion, and absorption by the intestine. This study aims to encapsulate rutin with three types of carrier materials using three different techniques and evaluate their antioxidant activity and bioactivity retention under in vitro gastrointestinal and dialysis conditions. Results showed that the rutin encapsulated lipid carrier has the highest radical inhibition activity for all the digestive phases, the highest singlet oxygen scavenging activity after the gastric phase and the highest anti-inflammatory activity for the dialyzable fraction. The rutin content of encapsulated lipid carriers for all the digestive phases was significantly higher (P≤0.05) comparatively. Fourier Transform Infrared spectroscopy, Particle size analysis, and Scanning Electron micrographs showed that rutin encapsulated lipid carrier was 1.7 μm with a polydispersity index of 0.909 indicating micro-encapsulation with heterogeneous dispersion.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:159 |
|---|---|
| Enthalten in: |
International journal of biological macromolecules - 159(2020) vom: 15. Sept., Seite 316-323 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mel, M M R D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
5G06TVY3R7 |
|---|
| Anmerkungen: |
Date Completed 19.03.2021 Date Revised 19.03.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijbiomac.2020.05.085 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310001951 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310001951 | ||
| 003 | DE-627 | ||
| 005 | 20231225135139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijbiomac.2020.05.085 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM310001951 | ||
| 035 | |a (NLM)32417545 | ||
| 035 | |a (PII)S0141-8130(20)33239-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mel, M M R D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Formulation of microencapsulated rutin and evaluation of bioactivity and stability upon in vitro digestive and dialysis conditions |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.03.2021 | ||
| 500 | |a Date Revised 19.03.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a Rutin, a flavanol, has been demonstrating excellent antioxidant, anti-inflammatory, anti-diabetic, and anti-carcinogenic properties. However, bioavailability is low due to low stability, solubility, digestion, and absorption by the intestine. This study aims to encapsulate rutin with three types of carrier materials using three different techniques and evaluate their antioxidant activity and bioactivity retention under in vitro gastrointestinal and dialysis conditions. Results showed that the rutin encapsulated lipid carrier has the highest radical inhibition activity for all the digestive phases, the highest singlet oxygen scavenging activity after the gastric phase and the highest anti-inflammatory activity for the dialyzable fraction. The rutin content of encapsulated lipid carriers for all the digestive phases was significantly higher (P≤0.05) comparatively. Fourier Transform Infrared spectroscopy, Particle size analysis, and Scanning Electron micrographs showed that rutin encapsulated lipid carrier was 1.7 μm with a polydispersity index of 0.909 indicating micro-encapsulation with heterogeneous dispersion | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a In-vitro digestion | |
| 650 | 4 | |a Lipid carriers | |
| 650 | 4 | |a Micro-encapsulation | |
| 650 | 4 | |a Rutin | |
| 650 | 4 | |a Stability | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Free Radical Scavengers |2 NLM | |
| 650 | 7 | |a Lipids |2 NLM | |
| 650 | 7 | |a Rutin |2 NLM | |
| 650 | 7 | |a 5G06TVY3R7 |2 NLM | |
| 650 | 7 | |a Starch |2 NLM | |
| 650 | 7 | |a 9005-25-8 |2 NLM | |
| 700 | 1 | |a Gunathilake, K D P P |e verfasserin |4 aut | |
| 700 | 1 | |a Fernando, C A N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 159(2020) vom: 15. Sept., Seite 316-323 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
| 773 | 1 | 8 | |g volume:159 |g year:2020 |g day:15 |g month:09 |g pages:316-323 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2020.05.085 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 159 |j 2020 |b 15 |c 09 |h 316-323 | ||